Search Results for '3tc Count'

3tc Count published presentations and documents on DocSlides.

Switch to DTG/ABC/3TC
Switch to DTG/ABC/3TC
by karlyn-bohler
STRIIVING . Study. Design. Endpoints. Primary: pr...
Switch to PI/r + 3TC
Switch to PI/r + 3TC
by lois-ondreau
vs. PI/r . monotherapy. Study PIVOT. Study MOBID...
Switch a ATV/r   3TC Estudio ATLAS-M
Switch a ATV/r 3TC Estudio ATLAS-M
by pamella-moone
ATV/r 300/100 mg QD 3TC 300 mg QD. N = 133. N =...
Switch to LPV/ r  + 3TC OLE
Switch to LPV/ r + 3TC OLE
by susan2
Study. LPV/. r. bid + 3TC or FTC . qd. + NRTI. N ...
Switch to DTG/3TC TANGO Design
Switch to DTG/3TC TANGO Design
by lam
Endpoints. Primary: proportion of patients with HI...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in
LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in
by lucy
Virologically. Suppressed. OLE Trial. LPV-RTV + ....
DTG + 3TC versus DTG + TDF-FTC as Initial ART
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
DTG/3TC 1st line (GEMINI)
DTG/3TC 1st line (GEMINI)
by oryan
ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...
Switching to TDF-FTC  from ABC-3TC for Hyperlipidemia
Switching to TDF-FTC from ABC-3TC for Hyperlipidemia
by trinity
ROCKET II. Switching to TDF-FTC from ABC-3TC . for...
EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC
EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC
by felicity
ACTG 5202. EFV versus ATV/r, both with ABC-3TC or ...
Switch to DOR-TDF-3TC vs. Continued Baseline Regimen
Switch to DOR-TDF-3TC vs. Continued Baseline Regimen
by dorothy
DRIVE SHIFT. Switch to Doravirine-TDF-3TC versus C...
Switch to DRV/r + 3TC DUAL Study
Switch to DRV/r + 3TC DUAL Study
by jireh
DRV/r 800/100 + 3TC 300 QD. N = 126. N = 123. DRV/...
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
by ricardo
ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...
Young person with multi-class resistance: follow-up and man
Young person with multi-class resistance: follow-up and man
by luanne-stotts
(with perspectives from well-resourced and resour...
Rationalizing Pediatric ARV Formularies:
Rationalizing Pediatric ARV Formularies:
by marina-yarberry
The IATT Optimal Pediatric ARV List. . Presented...
Switch to LPV/
Switch to LPV/
by lindy-dunigan
r. + 3TC. OLE . Study. LPV/. r. bid + 3TC or FT...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...
Treatment-Experienced Patients in Resource-Limited Settings
Treatment-Experienced Patients in Resource-Limited Settings
by pasty-toler
Susan M. Graham . Assistant Professor, Medicine a...
Treatment of Children and Adolescents
Treatment of Children and Adolescents
by liane-varnes
Implementation Challenges. Annette H. Sohn, MD. T...
Eric S.  Daar , MD Professor of Medicine
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
Fixed-Dose Combination of
Fixed-Dose Combination of
by myesha-ticknor
Doravirine. /Lamivudine/TDF is Non-Inferior to . ...
1 Fundación Huésped, Buenos Aires, Argentina;
1 Fundación Huésped, Buenos Aires, Argentina;
by aaron
2. Instituto Nacional de Ciencias Médicas y Nutr...
Comparative effectiveness of first-line antiretroviral therapy regimens: results from a large real-
Comparative effectiveness of first-line antiretroviral therapy regimens: results from a large real-
by min-jolicoeur
implementation of Dolutegravir. Meireles MV. , Pa...
Missing formulations for paediatric HIV treatment and the Dakar Call for
Missing formulations for paediatric HIV treatment and the Dakar Call for
by trish-goza
Action. Improving Access to Optimized Treatment ....
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
by myesha-ticknor
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
Eric S.  Daar , MD Professor of Medicine
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
Antiretroviral Therapy (ART)
Antiretroviral Therapy (ART)
by alexa-scheidler
Dr. S . Ntshalintshali. Ngwelezana. hospital. N...
Comparison of INSTI  vs  EFV
Comparison of INSTI vs EFV
by mediumgeneral
STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...
WHO ARV Forecasting Meeting
WHO ARV Forecasting Meeting
by sistertive
Geneva, March 19 - 20 , 2015 1 | Treatment and C...
Interactive ART Cases From the Clinic: Is There One Right Answer?
Interactive ART Cases From the Clinic: Is There One Right Answer?
by megan
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
Monday, 23 July, 10:15-12:15
Monday, 23 July, 10:15-12:15
by della
Hall 11B, RAI Amsterdam. Uptake and Procurement of...
Meg  Doherty MD MPH PhD 23 July 2018
Meg Doherty MD MPH PhD 23 July 2018
by jordyn
WHO HQ. The role of DTG based regimens in first- a...
Treatment Approaches to Achieve the 2
Treatment Approaches to Achieve the 2
by gabriella
nd. 90: Child Friendly Formulations . Victor Mu...
What’s new in the 2019 WHO Guidelines:
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
Dolutegravir-Lamivudine (
Dolutegravir-Lamivudine (
by audrey
Dovato. ). Last Updated: November 28, 2022. Prepar...
ADDP Training Programme Community Retail Pharmacy Drug Distribution Points
ADDP Training Programme Community Retail Pharmacy Drug Distribution Points
by jocelyn
(CRPDDP). Training Contents. Module 1. : . HIV Ove...
HIV IN CHILDREN WHAT WE DO AS KENYA AND WHY WE DO
HIV IN CHILDREN WHAT WE DO AS KENYA AND WHY WE DO
by hazel
Dr Laura Oyiengo. NATIONAL AIDS STI CONTROL PROGRA...
HIV 2020:  Time for change
HIV 2020: Time for change
by garcia
Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...